Avania, a medical technology CRO, has acquired Maxis, a medical technology development service provider with expertise in pre-clinical engineering, design validation and verification, regulatory affairs, field clinical services, and trial management. Maxis has offices in California, and Frankfurt. “This acquisition strengthens our position as the leading MedTech focused CRO,” said Sapna Hornyak, president and CEO….
Home Healthcare Markets International News Netherlands: Avania expands expertise in pre-clinical, clinical and regulatory consulting space with...